A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Recent college graduates are questioning the value of their computer science degrees because there aren't as many lucrative ...

AI companies such as OpenAI and Anthropic have long focused on building tools that can write code that will speed up software ...

In 2025, Anthropic will grow from $1 billion to $9 billion in ARR (annual recurring revenue). OpenAI, meanwhile, will go from ...

One solution to the skills shortage is to encourage more young people to learn vocational skills. But there is still a stigma ...

In this Monday edition of quantum computing news, we look at a new push by SEALSQ ($LAES) to build silicon-based quantum systems, Xanadu’s early ...

At M.I.T., a new program called “artificial intelligence and decision-making” is now the second-most-popular undergraduate major. By Natasha Singer Natasha Singer covers computer science and A.I.

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research ...